Samer Alsaid։ Older Patients With Atrial Fibrillation Benefit From FXI Inhibition
Samer Alsaid, Cardiologist and Vascular Medicine Specialist, shared a post on LinkedIn about a recent article he co-authored with his colleagues, adding:
՛՛Bleeding risk rises steadily with age in patients with atrial fibrillation — underscoring the need for safer anticoagulant options in older individuals.
In our prespecified analysis of the phase 2b AZALEA-TIMI 71 trial, now published in JAMA Cardiology, the FXI inhibitor abelacimab consistently reduced bleeding compared with rivaroxaban across age groups, with the potential for greater absolute reductions in older patients.
FXI inhibition may become a particularly attractive option for older patients with AF, but phase 3 trial results are needed to define its efficacy and overall benefit-risk balance.
Grateful to an outstanding group of collaborators, mentors, and the AZALEA-TIMI 71 investigators who made this work possible․՛՛
Title: Abelacimab vs Rivaroxaban in Older Individuals With Atrial Fibrillation
Authors: Samer Al Said, Siddharth M. Patel, Robert P. Giugliano, David A. Morrow, Erica L. Goodrich, Sabina A. Murphy, Bruce Hug, Sanobar Parkar, Shih-Ann Chen, Shaun G. Goodman, Boyoung Joung, Robert G. Kiss, Wojciech Wojakowski, Jeffrey I. Weitz, Dan Bloomfield, Marc S. Sabatine, Christian T. Ruff
Read the Full Article on JAMA Cardiology․
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 10, 2026, 14:59Michiel Voet: A Brief History of Blood Transfusion – From Discovery to Modern Medicine
-
Feb 10, 2026, 14:56Armen Melkonyan: Supporting Armenia-Led Resolution on Hemophilia and Health Equity at WHO
-
Feb 10, 2026, 14:50Thirumalai Raj R: 35 Donations, 13 Years of Service, Turned Away for Riding a Bike
-
Feb 10, 2026, 14:49Eugene Tang: Thrilled to Collaborate With Eirini Kontou and Jade Kettlewell On e-OPTIMISM for Minor Stroke Patients
-
Feb 10, 2026, 14:43Simon Mooijaart: When Is the Right Time to Stop Antithrombotics at the End of Life?
-
Feb 10, 2026, 14:38Christian Schulze: Insights from DANGERSHOCK on Bleeding in IMPELLA Patients
-
Feb 10, 2026, 14:32Abdulla A. Damluji Summarizes CORAL Reef Trial
-
Feb 10, 2026, 14:27Alan Nurden: Discovering Platelet PITTs and a New Phenomenon in Biology
-
Feb 10, 2026, 14:25Charles Okyere Boadu: Safe Blood Saves Lives, Safer Blood Protects Futures